Sunday April 23, 2017 20:53

Food and Healthcare Press Releases

INSIGHTEC: First Patient with Benign Brain Tumor has Focused Ultrasound Procedure at Nicklaus Heathcare—21 Apr 17

INSIGHTEC [ ] congratulates Nicklaus Children's Hospital [ ], part of the Miami Children's Health System, for performing the first focused ultrasound procedure on a 21-year old patient

Grifols Donates 140 Million International Units of Blood Clotting Factors to the World Federation Heathcare—18 Apr 17

Helping treat tens-of-thousands of patients in developing countries; renewing partnership with WFH; reaffirming commitment to improving the lives of patients around the world Today, Grifols, S.A. (MCE:GRF, MCE:GRF.P and NASDAQ:GRFS) announced that it

HIMSS Asia Pacific and Elsevier Announce Call for Submissions for the 5th HIMSS-Elsevier Digital Heathcare—17 Apr 17

HIMSS Asia Pacific and Elsevier , the information analytics company specializing in science and health, are proud to announce the call for submissions for the fifth Asia Pacific HIMSS-Elsevier Digital Healthcare Award 2017. The HIMSS-Elsevier Digital

Multisorb Technologies to Showcase the Uhlmann Bottle line IBC 150 with Fully-Integrated Heathcare—11 Apr 17

Multisorb Technologies, Inc. of Buffalo, New York, USA, and Uhlmann Pac-Systeme GmbH & Co. KG of Laupheim, Germany have announced that Uhlmann will be exhibiting their Bottle line IBC 150 featuring a fully-integrated Multisorb MultiPacket(TM) system

Four Ways to Eat Yourself into Good Health Heathcare—07 Apr 17

You are what you eat. This proverb is present for many of us throughout our lives — serving as both friend, and foe. Ultimately, the lesson is that food forms a large part of our overall health, helping balance our bodies, giving us energy,

Successful Financial Year 2016 for Boehringer Ingelheim Heathcare—07 Apr 17

- Net sales rise to some 15.9 billion euros (currency-adjusted: +7.3 per cent; in euro terms: +7.1 per cent) - Operating income improves to around 2.9 billion euros - Corporate strategy successfully implemented The research-driven pharmaceutical company

Occlutech Obtains European CE Mark for its Novel PmVSD Occluder Heathcare—07 Apr 17

Occlutech, a leading innovator of implants to treat structural heart disease, today announced that it has obtained European CE Mark approval for its Perimembranous Ventricular Septal Defect (PmVSD) Occluder. The device is a specifically designed implant

Merck Introduces Next-Generation High-Sensitivity Protein Detection Heathcare—04 Apr 17

- New SMCxPRO(TM) technology offers high speed, high sensitivity for single molecule detection - Meets customer demand for biomarker and novel target discovery and detection Merck , a leading science and technology company, today announced the launch

Once-weekly Semaglutide Demonstrated Consistent Blood Glucose Reductions and Weight Loss Regardless Heathcare—03 Apr 17

Findings from a post hoc analysis of the phase 3a SUSTAIN 2-4 trials demonstrated greater mean reductions in HbA1c and body weight with once-weekly semaglutide treatment compared to sitagliptin, exenatide extended release (ER) and insulin glargine U100

Symetis and Boston Scientific Reach USD 435 Million Purchase Agreement Heathcare—30 Mar 17

- Definitive purchase agreement whereby Boston Scientific will acquire Symetis for $435 million in an all cash, up-front payment - Acquisition of Symetis will expand the treatment offerings for patients with aortic valvular heart disease - Acquisition

The Mikey Czech Foundation Contributes $1 Million To DIPG Research At Dana-Farber Cancer Heathcare—30 Mar 17

The Mikey Czech Foundation, Inc. (the "Foundation", ) a 501(c)(3) non-profit foundation established by Stephen J. and Jennifer L. Czech to finance medical research for pediatric brain tumors, announced a $1,000,000 gift to Pediatric

New Blood for the world 9th year - Bangkok Hospital Pattaya Heathcare—29 Mar 17

Bangkok Hospital Pattaya in cooperation with Queen Savang Vadhana Memorial Hospital (Somdej Pra Boromrajthevi na Sriracha) and the Thai Red Cross Society, have combined for another Blood Donation project. On Thursday 23rd March 2017 from 9.30 a.m.

Fiasp(R)Black Triangle Drug, a new, ultra-fast acting mealtime insulin is available for the Heathcare—27 Mar 17

Today, Novo Nordisk announced that Fiasp(R), a new, fast-acting mealtime insulin for the treatment of diabetes in adults, has been launched in Canada, following the recent marketing authorisation from Health Canada on 6 January 2017. Fiasp(R) is insulin

FDA Grants Approval for BAVENCIO(R) (avelumab), the First Immunotherapy Approved for Metastatic Heathcare—24 Mar 17

- Only FDA-approved treatment for metastatic Merkel cell carcinoma, a rare and aggressive skin cancer - First indication for BAVENCIO, a human anti-PD-L1 antibody Merck and Pfizer Inc. (NYSE: PFE) today announced that the US Food and Drug Administration

Rajanukul Institute Honored for Pioneering Global Health Work with First-ever Golisano Global Heathcare—21 Mar 17

The Golisano Foundation and Special Olympics, the largest public health organization for people with intellectual disabilities (ID), honored the Rajanukul Institute, Ministry of Public Health, Thailand in Bangkok, Thailand for launching a national health

Truth or Myth? Global Survey for World Oral Health Day Exposes the Truth About our Oral Health Heathcare—20 Mar 17

Today on World Oral Health Day , FDI World Dental Federation is myth busting what people around the world believe to be good oral health practices, encouraging them to become better informed and take action. Oral health is integral to our general health

ISABS เตรียมจัดการประชุมว่าด้วยการแพทย์ส่วนบุคคลที่โครเอเชีย มิ.ย.นี้ Heathcare—16 Mar 17

International Society for Applied Biological Sciences (ISABS), Mayo Clinic และ St. Catherine Hospital ร่วมด้วย Philips เตรียมจัดการประชุม "The Tenth ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized

ISABS: Personalized Medicine Conference with Nobel Prize Laureates Participation to be held in Heathcare—16 Mar 17

International Society for Applied Biological Sciences (ISABS), Mayo Clinic and St. Catherine Hospital in partnership with Philips are organizing "The Tenth ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized

HIMSS Asia Pacific ผนึกกำลัง Singapore Nurses Association และ Integrating the Health Enterprise Heathcare—14 Mar 17

HIMSS Asia Pacific ประกาศผนึกกำลังกับ Singapore Nurses Association (SNA) และ Integrating the Health Enterprise (IHE) จัดกิจกรรมที่น่าสนใจทั้งก่อนและระหว่างการประชุม HIMSS AsiaPac17 ซึ่งจะจัดขึ้นระหว่างวันที่ 11-14 กันยายนนี้ ณ โรงแรม Marina Bay Sands

HIMSS Asia Pacific Announces Program Partnerships with Singapore Nurses Association and Integrating Heathcare—14 Mar 17

HIMSS Asia Pacific announced today that it will be joining forces with Singapore Nurses Association (SNA) and Integrating the Health Enterprise (IHE) to offer pre-conference and main conference programs for delegates at this year's HIMSS AsiaPac17

New Merck Technology Aims to Further Optimize Embryo Incubation and Heathcare—10 Mar 17

- Merck integrates innovative Eeva(R) Test with Geri(TM) incubation platform, bringing individualized incubation and outcome prediction together - Geri(TM) humidity technology aims to further advance incubation to precisely monitor and manage the

Dr. Guislain Museum and Janssen Seek Nominations for 2017 Breaking the Chains of Stigma Heathcare—10 Mar 17

The Dr. Guislain Museum in Ghent, Belgium and Janssen Research & Development, LLC ("Janssen"), today announced that they are seeking nominations for the sixth annual Dr. Guislain "Breaking the Chains of Stigma" Award. The Award honors an individual,

LEO Pharma Announces Positive Results From Phase 2b Clinical Study for Tralokinumab in Atopic Heathcare—06 Mar 17

LEO Pharma today announced positive results from a Phase 2b dose-ranging efficacy and safety study of tralokinumab in adult patients with moderate to severe atopic dermatitis (AD), a serious and chronic form of eczema. Tralokinumab is an investigational

NICE Expands Positive Recommendation for Erbitux as First-line Treatment for RAS Wild-type Heathcare—02 Mar 17

- More patients now able to receive a standard-of-care treatment with Erbitux plus FOLFIRI or FOLFOX - NICE's recommendation is a significant step forward in Merck's aspiration to ensure cancer patients have optimal access to effective treatments